191 related articles for article (PubMed ID: 27707751)
1. Dilemmas With Race and Heart Failure Treatment.
Butler J; Konstam MA
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707751
[No Abstract] [Full Text] [Related]
2. Have we witnessed the rise and fall of race-specific drugs?
Coons SJ
Clin Ther; 2009 Mar; 31(3):620-2. PubMed ID: 19393852
[No Abstract] [Full Text] [Related]
3. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
5. Color blind, or just plain blind?
Czap A
Altern Med Rev; 2005 Jun; 10(2):81-2. PubMed ID: 16032786
[No Abstract] [Full Text] [Related]
6. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
[TBL] [Abstract][Full Text] [Related]
7. Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
Pharmacogenomics; 2005 Jul; 6(5):455. PubMed ID: 16705760
[No Abstract] [Full Text] [Related]
8. Isosorbide dinitrate and hydralazine in blacks with heart failure.
Eisenberger AB
N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761995
[No Abstract] [Full Text] [Related]
9. Novel heart failure drug may offer options for you.
Heart Advis; 2005 Sep; 8(9):2. PubMed ID: 16637097
[No Abstract] [Full Text] [Related]
10. Race, drugs, and heart failure.
Aronow WS
Geriatrics; 2005 Jul; 60(7):8-9. PubMed ID: 16026175
[No Abstract] [Full Text] [Related]
11. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Colvin-Adams M; Taylor AL
Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
[TBL] [Abstract][Full Text] [Related]
12. Ethnic pharmacology: science, research, race, and market share.
O'Malley P
Clin Nurse Spec; 2005; 19(6):291-3. PubMed ID: 16294053
[No Abstract] [Full Text] [Related]
13. Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?
Ruel MD
J Leg Med; 2006 Jun; 27(2):225-41. PubMed ID: 16728354
[No Abstract] [Full Text] [Related]
14. The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
Ferdinand KC
J Clin Hypertens (Greenwich); 2006 Mar; 8(3):156-8. PubMed ID: 16522991
[No Abstract] [Full Text] [Related]
15. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Echols MR; Yancy CW
Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
[TBL] [Abstract][Full Text] [Related]
16. Race and a heart drug.
Peota C
Minn Med; 2005 Mar; 88(3):11. PubMed ID: 15852585
[No Abstract] [Full Text] [Related]
17. "Special treatment": BiDil, Tuskegee, and the logic of race.
Reverby SM
J Law Med Ethics; 2008; 36(3):478-84. PubMed ID: 18840239
[TBL] [Abstract][Full Text] [Related]
18. Postcards: race and medicine in the 21st century.
Tutton R
Br J Gen Pract; 2004 Sep; 54(506):716-7. PubMed ID: 15558866
[No Abstract] [Full Text] [Related]
19. BiDil for heart failure.
Med Lett Drugs Ther; 2005 Sep; 47(1218):77-8. PubMed ID: 16186789
[TBL] [Abstract][Full Text] [Related]
20. Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
Dorr GM; Jones DS
J Law Med Ethics; 2008; 36(3):443-8. PubMed ID: 18840234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
